Terra Quantum, has unveiled a groundbreaking medical innovation targeting cardiovascular disease, the world’s leading cause of mortality. Developed in Munich, Bavaria, Germany, the company’s next-generation medical laser system utilizes a patented real-time feedback mechanism to precisely deliver energy into biological tissue, inducing microscopic mechanical and structural changes without causing thermal damage. This controlled, non-destructive remodeling restores elasticity to stiffened tissue, potentially offering a solution to a disease costing the U.S. healthcare system over $100 billion annually and currently addressed only by delaying treatments with stents and drugs.
Terra Quantum’s Laser Technology for Cardiovascular Disease
Terra Quantum has developed a new laser system aimed at treating cardiovascular disease, the world’s leading cause of mortality. Current treatments like stents and drugs only delay disease progression; this technology seeks to restore arterial flexibility at a microscopic level. The system utilizes a patented, real-time feedback mechanism for precise energy delivery, avoiding thermal damage and instead inducing controlled, non-destructive remodeling of calcified or stiffened tissue.
Early proof-of-concept results demonstrate significant improvements using this laser technology. Specifically, testing showed a 28% increase in arterial lumen area and a 2.4x improvement in arterial compliance. This “cold lithotripsy” approach offers a safe, minimally invasive treatment option. The scientific basis for this innovation has been published in Frontiers in Cardiovascular Medicine.
Terra Quantum is currently collaborating with Baylor College of Medicine to advance this technology towards clinical application. Development includes building a prototype laser device, performing testing and calibration with advanced imaging, and conducting clinical trials. The ultimate goal is to achieve FDA 510(k) approval, bringing this potential new treatment option to patients.
Restoring Arterial Flexibility with Precision Laser Remodeling
Terra Quantum has developed a laser system designed to restore arterial flexibility at a microscopic level, addressing limitations of current treatments like stents and drugs which only delay disease progression. This new technology utilizes a patented real-time feedback mechanism to precisely deliver energy, inducing microscopic mechanical and structural changes without harming surrounding cells. The goal is to remodel calcified or stiffened tissue, offering a minimally invasive approach to cardiology, orthopedics, and ophthalmology.
Early proof-of-concept results demonstrate the potential of this laser technology to improve arterial health. Testing showed a 28% increase in arterial lumen area and a 2.4x improvement in arterial compliance. This “cold lithotripsy” technology works by remodeling calcified plaques without causing thermal damage, making it a safe and minimally invasive treatment option.
Terra Quantum is collaborating with Baylor College of Medicine to advance this innovation, currently focused on developing a prototype device and preparing for clinical trials. The company anticipates pursuing FDA 510(k) approval, ultimately aiming to apply this quantum technology to combat cardiovascular disease—the world’s leading cause of mortality—and improve human health.
Our new laser solution restores arterial flexibility at the microscopic level, offering hope for healing of millions of people worldwide.
Markus Pflitsch, Founder & CEO of Terra Quantum
Advancing Toward Clinical Trials and FDA Approval
Terra Quantum is actively working toward clinical application of its new laser technology for cardiovascular disease, the world’s leading cause of mortality. The company is collaborating with Baylor College of Medicine in Texas to develop a prototype laser device and refine it through testing and calibration with advanced imaging methods. This work is intended to pave the way for clinical trials, ultimately seeking FDA 510(k) approval for the innovative treatment.
Early proof-of-concept results demonstrate the potential of this laser system to remodel calcified plaques without damaging surrounding tissue. Specifically, testing showed a 28% increase in arterial lumen area and a 2.4x improvement in arterial compliance. This “cold lithotripsy” technology aims to restore arterial flexibility at the microscopic level, addressing limitations of current treatments like stents and drugs which only delay disease progression.
The technology utilizes ultrafast computing and a patented real-time feedback mechanism to precisely control energy delivery into biological tissue. Terra Quantum anticipates this innovation will significantly impact healthcare, given that direct healthcare costs of heart disease in the U.S. alone exceed $100 billion annually. The company views this as a key step in applying quantum technology to address major human health challenges.
